These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27798548)

  • 1. Growth at 2 Years of Age in HIV-exposed Uninfected Children in the United States by Trimester of Maternal Antiretroviral Initiation.
    Jacobson DL; Patel K; Williams PL; Geffner ME; Siberry GK; DiMeglio LA; Crain MJ; Mirza A; Chen JS; McFarland E; Kacanek D; Silio M; Rich K; Borkowsky W; Van Dyke RB; Miller TL;
    Pediatr Infect Dis J; 2017 Feb; 36(2):189-197. PubMed ID: 27798548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
    le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
    Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study.
    Williams PL; Yildirim C; Chadwick EG; Van Dyke RB; Smith R; Correia KF; DiPerna A; Seage GR; Hazra R; Crowell CS;
    Lancet HIV; 2020 Jan; 7(1):e49-e58. PubMed ID: 31740351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers.
    Lipshultz SE; Williams PL; Zeldow B; Wilkinson JD; Rich KC; van Dyke RB; Seage GR; Dooley LB; Kaltman JR; Siberry GK; Mofenson LM; Shearer WT; Colan SD;
    AIDS; 2015 Jan; 29(1):91-100. PubMed ID: 25562493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower birth weight-for-age and length-for-age z-scores in infants with in-utero HIV and ART exposure: a prospective study in Cape Town, South Africa.
    Nyemba DC; Kalk E; Madlala HP; Malaba TR; Slogrove AL; Davies MA; Boulle A; Myer L; Powis KM
    BMC Pregnancy Childbirth; 2021 May; 21(1):354. PubMed ID: 33947351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana.
    Powis KM; Smeaton L; Hughes MD; Tumbare EA; Souda S; Jao J; Wirth KE; Makhema J; Lockman S; Fawzi W; Essex M; Shapiro RL
    AIDS; 2016 Jan; 30(2):211-20. PubMed ID: 26684818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Effects of In Utero Antiretroviral Exposure: Systolic and Diastolic Function in HIV-Exposed Uninfected Youth.
    Guerra V; Leister EC; Williams PL; Starc TJ; Lipshultz SE; Wilkinson JD; Van Dyke RB; Hazra R; Colan SD
    AIDS Res Hum Retroviruses; 2016 Jul; 32(7):621-7. PubMed ID: 26794032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Utero Exposure to Antiretroviral Drugs: Effect on Birth Weight and Growth Among HIV-exposed Uninfected Children in Brazil.
    Hofer CB; Keiser O; Zwahlen M; Lustosa CS; Frota AC; de Oliveira RH; Abreu TF; Carvalho AW; Araujo LE; Egger M
    Pediatr Infect Dis J; 2016 Jan; 35(1):71-7. PubMed ID: 26741583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Growth of uninfected infants exposed to antiretrovirals born to HIV-infected woman].
    Fernández Ibieta M; Bellón Cano JM; Ramos Amador JT; González-Tomé MI; Guillén Martín S; Navarro Gómez M; De José MI; Beceiro J; Iglesias E; Prieto L; Santos MJ; Martínez Guardia N; Roa MA; Regidor J
    An Pediatr (Barc); 2009 Oct; 71(4):299-309. PubMed ID: 19660998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meconium Tenofovir Concentrations and Growth and Bone Outcomes in Prenatally Tenofovir Exposed HIV-Uninfected Children.
    Himes SK; Wu JW; Jacobson DL; Tassiopoulos K; Hazra R; Kacanek D; Van Dyke RB; Rich KC; Siberry GK; Huestis MA;
    Pediatr Infect Dis J; 2015 Aug; 34(8):851-7. PubMed ID: 25961889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the Caribbean.
    Spaulding AB; Yu Q; Civitello L; Mussi-Pinhata MM; Pinto J; Gomes IM; Alarcón JO; Siberry GK; Harris DR; Hazra R
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):349-56. PubMed ID: 26879281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth of human immunodeficiency type 1-infected and uninfected children: a prospective cohort study in Kigali, Rwanda, 1988 to 1993.
    Lepage P; Msellati P; Hitimana DG; Bazubagira A; Van Goethem C; Simonon A; Karita E; Dequae-Merchadou L; Van de Perre P; Dabis F
    Pediatr Infect Dis J; 1996 Jun; 15(6):479-85. PubMed ID: 8783343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Children Exposed or Unexposed to Human Immunodeficiency Virus: Weight, Height, and Body Mass Index During the First 5 Years of Life-A Danish Nationwide Cohort.
    Moseholm E; Helleberg M; Sandholdt H; Katzenstein TL; Storgaard M; Pedersen G; Johansen IS; Weis N
    Clin Infect Dis; 2020 May; 70(10):2168-2177. PubMed ID: 31271208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte Telomere Length at Birth and During the Early Life of Children Exposed to but Uninfected With HIV After In Utero Exposure to Antiretrovirals.
    Ajaykumar A; Soudeyns H; Kakkar F; Brophy J; Bitnun A; Alimenti A; Albert AYK; Money DM; Côté HCF; ;
    J Infect Dis; 2018 Feb; 217(5):710-720. PubMed ID: 29228317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-utero exposure to antiretrovirals and neurodevelopment among HIV-exposed-uninfected children in Botswana.
    Chaudhury S; Mayondi GK; Williams PL; Leidner J; Shapiro R; Diseko M; Ajibola G; Holding P; Tepper V; Makhema J; Petlo C; Seage GR; Lockman S; Kammerer B
    AIDS; 2018 Jun; 32(9):1173-1183. PubMed ID: 29547434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.
    Williams PL; Hazra R; Van Dyke RB; Yildirim C; Crain MJ; Seage GR; Civitello L; Ellis A; Butler L; Rich K;
    AIDS; 2016 Jan; 30(1):133-44. PubMed ID: 26731758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Growth of HIV-exposed Uninfected Infants in Ethiopia According to Timing of In-utero Antiretroviral Therapy Exposure.
    Ejigu Y; Magnus JH; Sundby J; Magnus MC
    Pediatr Infect Dis J; 2020 Aug; 39(8):730-736. PubMed ID: 32516280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Child Growth According to Maternal and Child HIV Status in Zimbabwe.
    Omoni AO; Ntozini R; Evans C; Prendergast AJ; Moulton LH; Christian PS; Humphrey JH
    Pediatr Infect Dis J; 2017 Sep; 36(9):869-876. PubMed ID: 28198792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
    Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
    Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United States.
    Kirmse B; Yao TJ; Hofherr S; Kacanek D; Williams PL; Hobbs CV; Hazra R; Borkowsky W; Van Dyke RB; Summar M
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):339-48. PubMed ID: 26548585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.